3.Report of the National commission on Sleep Disorders Research. Wake Up America: A National Sleep Alert. Washington D.C, U.S. Government Printing Office, 1995.
4.Ball EM, Simon RD Jr, Tall AA, et al. Diagnosis and treatment of sleep apnea within the community. The Walla Walla project. Arch Intern Med 1997;157:419–424.
5.Young T, Palta M, Dempsey J, et al. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230–1235.
6.Penzel T, Peter JH. Ambulatory diagnosis of sleep-related breathing disorders. Sleep 1992;15:S9–S12.
7.Shahar E, Whitney CW, Readline S, et al. Sleep disordered breathing and cardiovascular disease: cross sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19–25.
8.Sin D, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101–1106.
9.Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562–567.
10.Javaheri S, Parker TJ, Wexler L, et al. Occult sleep–disordered breathing in stable congestive heart failure patients. Ann Intern Med 1995;122:487–492.
11.Shulz R, Blau A, Börgel J, et al. Sleep apnoea in heart failure. Eur Respir J 2007;29:1201–1205.
12.Javeheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalence's, consequences, and presentations. Circulation 1998;97:2154–2159.
13.Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008;52:686–717.
14.MacDonald M, Fang J, Pittman SD, et al. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med 2008;4:38–42.
15.Mookadam F, Calvin AD, Somers VK. Prevalence and management of central sleep apnea in heart failure patients. Curr Heart Fail Rep 2008;5:233–237.
16.Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625–1631.
17.Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stoke respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996;153:272–276.
18.Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99:1435–1440.
20.Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034–2041.
21.Caples SM, Garcia-Touchard A, Somers VK. Sleep-disordered breathing and cardiovascular risk. Sleep 2007;30:291–303.
22.Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–1384.
23.Spurr KF, Graven MA, Gilbert RW. Prevalence of unspecified sleep apnea and the use of continuous positive airway pressure in hospitalized patients, 2004 National Hospital Discharge Survey. Sleep Breath 2008;12:229–234.
24.Eckert DJ, Jordan AS, Merchia P, et al. Central sleep apnea: pathophysiology and treatment. Chest 2007;131:595–607.
25.Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001;164:2147–2165.
26.Kryger MH, RothT, Dement WC. Principles and Practice of Sleep Medicine. Philadelphia, Elsevier, 2005.
27.Andreas S, Schulz R, Werner GS, et al. Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis 1996;76:541–545.
28.Elmasry A, Lindberg A, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001;249:153–161.
29.Hu FB, Willett WC, Colditz GA, et al. Prospective study of snoring and risk of hypertension in women. Am J Epidemiol 1999;150:806–816.
30.Hu FB, Willett WC, Manson JE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol 2000;35:308–313.
31.Liu KH, Chu WC, To KW, et al. Sonographic measurement of lateral parapharyngeal wall thickness in patients with obstructive sleep apnea. Sleep 2007;30:1503–1508.
32.Flemons WW, Remmers JE, Whitelaw WA, et al. The clinical prediction of obstructive sleep apnea. Am Rev Respir Dis 1992;145:A722.
33.Katz I, Stradling J, Slutsky AS, et al. Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis 1990;141:1228–1231.
34.Arzt M, Young T, Finn L, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006;166:1716–1722.
35.DeZee KJ, Hatzigeorgiou C, Kristo D, et al. Prevalence of and screening for mental disorders in a sleep clinic. J Clin Sleep Med 2005;1:136–142.
36.Endeshaw Y. Clinical characteristics of obstructive sleep apnea in community-dwelling older adults. J Am Geriatr Soc 2006;54:1740–1744.
37.Lettieri CJ, Eliasson AH, Andrada T, et al. Obstructive sleep apnea syndrome: are we missing an at-risk population? J Clin Sleep Med 2005;1:381–385.
38.Victor LD. Treatment of obstructive sleep apnea in primary care. Am Fam Physician 2004;69:561–568.
39.Bradley TD, Floras JS. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 2003;107:1671–1678.
40.Palmer S, Selvaraj S, Dunn C, et al. Annual review of patients with sleep apnea/hypopnea syndrome—a pragmatic randomised trial of nurse home visit versus consultant clinic review. Sleep Med 2004;5:61–65.
41.Issa FG, Sullivan CE. Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry 1985;45:353–359.
42.Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004;169:361–366.
43.Kasai T, Narui K, Dohi T, et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008;133:690–696.
44.Lin CC, Lee KS, Wang YP, et al. Effect of uvulopalatopharyngoplasty on work of breathing during wakefulness in obstructive sleep apnea syndrome. Ann Otol Rhinol Laryngol 2007;116:271–277.
45.Yap WS, Fleetham JA. Central sleep apnea and hypoventilation syndrome. Curr Treat Options Neurol 2001;3:51–56.
46.Thalhofer S, Dorow P. Central sleep apnea. Respiration 1997;64:2–9.
47.Sanders MH, Givelber R. Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. Sleep Med 2003;4:349–350.
48.Javaheri S. Central sleep apnea in congestive heart failure: prevalence, mechanisms, impact, and therapeutic options. Semin Respir Crit Care Med 2005;26:44–55.
49.Szollosi I, Roebuck T, Thompson B, et al. Lateral sleeping position reduces severity of central sleep apnea/Cheyne-Stokes respiration. Sleep 2006;29:1045–1051.
50.Szollosi I, Krum H, Kaye D, et al. Sleep apnea in heart failure increases heart rate variability and sympathetic dominance. Sleep 2007;30:1509–1514.
51.Iber C. Sleep-related breathing disorders. Neurol Clin 2005;23:1045–1057.
52.Kuzniar TJ, Pusalavidyasagar S, Gay PC, et al. Natural course of complex sleep apnea—a retrospective study. Sleep Breath 2007;12:135–139.
53.Smith S, Sullivan KA. A reliable change index (RCI) for the Epworth sleepiness scale (ESS). Sleep Med 2007;9:102.
54.Bradley TD, Floras JS. Sleep apnea and heart failure: part II: central sleep apnea. Circulation 2003;107:1822–1826.
55.Aronow WS. Treatment of heart failure with normal left ventricular ejection fraction. Compr Ther 2007;33:223–230.
56.Tamura A, Kawano Y, Naono S, et al. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007;131:130–135.
57.Sasayama S, Izumi T, Seino Y, et al; CHF-HOT Study Group. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J 2006;70:1–7.
58.Arzt M, Floras JS, Logan AG, et al; CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007;115:3173–3180.
59.Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000;102:61–66.
60.Bradley TD, Logan AG, Kimoff RJ, et al; CANPAP Investigators. Continous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025–2033.
61.International Classification of Sleep Disorder (ICSD), Revised Diagnostic and Coding Manual. Available at: http://www.absm.org/PDF/ICSD.pdf
. Accessed January 14, 2009.
62.Ballard RD, Gay PC, Strollo PJ. Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med 2007;3:706–712.
63.Shigemitsu M, Nishio K, Kusuyama T, et al. Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea. Int J Cardiol 2007;115:354–360.
64.Banno K, Okamura K, Kryger MH. Adaptive servo-ventilation in patients with idiopathic Cheyne-Stokes breathing. J Clin Sleep Med 2006;2–186.
65.Pepperell JC, Maskell NA, Jones DR, et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003;168:1109–1114.
66.Philippe C, Stoïca-Herman M, Drouot X, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne- Stokes respiration in heart failure over a six month period. Heart 2006;92:337–342.
67Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006;173:234–237.
68.Peña F, García O. Breathing generation and potential pharmacotherapeutic approaches to central respiratory disorders. Curr Med Chem 2006;13:2681–2693.
69.Javaheri S, Ahmed M, Parker TJ, et al. Effect of nasal O2 on sleep-related breathing in ambulatory patients with heart failure. Sleep 1999;22:1101–1106.